Christensen M, Vedtofte L, Holst JJ, Vilsbll T, Knop FK (2011) Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans
This makes retatrutide one of the first therapies to show real potential in addressing this fast-growing condition, which is often linked to obesity and diabetes
Mounjaro is primarily indicated for adults with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher accompanied by weight-related health conditions, such as hypertension or type 2 diabetes
Since Ozempic became a household name, using diabetes medications off-label for weight loss has become increasingly common
Frustrated that even GLP-1 medications aren't giving you the results you expected
Kim R, Nijhout HF, Reed MC